Loading...
-
ΗΠΑΡ
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| EASL | 2025 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2825%2900173-4 | EASL Clinical Practice Guidelines on the management of autoimmune hepatitis |
| EASL | 2022 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900326-9 | EASL Clinical Practice Guidelines on sclerosing cholangitis |
| AASLD | 2021 | https://journals.lww.com/hep/fulltext/2022/04000/primary_biliary_cholangitis__2021_practice.24.aspx | Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases |
| AASLD | 2019 | https://journals.lww.com/hep/fulltext/2020/08000/diagnosis_and_management_of_autoimmune_hepatitis.24.aspx | Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases |
| AASLD | 2018 | https://journals.lww.com/hep/Fulltext/2019/01000/Primary_Biliary_Cholangitis__2018_Practice.32.aspx | Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases |
| ESGE | 2017 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2817%2930108-3 | Role of endoscopy in primary sclerosing cholangitis : European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline |
| EASL | 2017 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2817%2930186-1 | EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| AASLD/IDSA | 2025 | https://journals.lww.com/hep/abstract/9900/aasld_idsa_practice_guideline_on_treatment_of.1416.aspx | AASLD/IDSA Practice Guideline on treatment of chronic hepatitis B |
| AGA | 2025 | https://www.gastrojournal.org/article/S0016-5085(24)05744-5/fulltext | AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals |
| AASLD | 2018 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5975958/ | Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance |
| EASL | 2025 | https://www.journal-of-hepatology.eu/article/S0168-8278(25)00174-6/fulltext | EASL Clinical Practice Guidelines on the management of hepatitis B virus infection |
| AASLD | 2016 | https://journals.lww.com/hep/Fulltext/2016/01000/AASLD_guidelines_for_treatment_of_chronic.32.aspx |
AASLD guidelines for treatment of chronic hepatitis B |
| EASL | 2024 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2824%2900275-7 | EASL position paper on clinical follow-up after HCV cure |
| AASLD | 2023 | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciad319/7179952?login=false | Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection |
| EASL | 2020 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2820%2930548-1 | EASL recommendations on treatment of hepatitis C: Final update of the series |
| EASL | 2023 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2823%2900317-3 | EASL Clinical Practice Guidelines on hepatitis delta virus |
| EASL | 2018 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2818%2930155-7 | EASL Clinical Practice Guidelines on hepatitis E virus infection |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| EASL | 2025 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2825%2900066-2 | EASL Clinical Practice Guidelines on TIPS |
| EASL | 2025 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2825%2900235-1 | EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease |
| AGA | 2025 | https://www.gastrojournal.org/article/S0016-5085(24)05664-6/fulltext | AGA Clinical Practice Update on Management of Portal Vein Thrombosis in Patients With Cirrhosis: Expert Review |
| AASLD | 2024 | https://journals.lww.com/hep/fulltext/2024/05000/aasld_practice_guidance_on_risk_stratification_and.22.aspx | AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis |
| AGA | 2022 | https://www.cghjournal.org/article/S1542-3565(22)00829-1/fulltext | AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review |
| AASLD | 2022 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9942270/ | AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis |
| EASL | 2022 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2821%2902033-X | EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis |
| EASL | 2022 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900346-4 | EASL Clinical Practice Guidelines on the management of hepatic encephalopathy |
| AGA | 2021 | https://www.gastrojournal.org/article/S0016-5085(21)03382-5/fulltext | AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis |
| AASLD | 2021 | https://journals.lww.com/hep/fulltext/2021/09000/malnutrition,_frailty,_and_sarcopenia_in_patients.38.aspx | Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases |
| AASLD | 2021 | https://journals.lww.com/hep/fulltext/2021/08000/diagnosis,_evaluation,_and_management_of_ascites,.38.aspx | Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases |
| EASL | 2018 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2818%2931966-4 | EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis |
| AASLD | 2014 | https://journals.lww.com/hep/Fulltext/2014/08000/Hepatic_encephalopathy_in_chronic_liver_disease_.30.aspx | Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| EASL | 2024 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2824%2902440-1 | EASL Clinical Practice Guidelines on liver transplantation |
| AASLD | 2024 | https://journals.lww.com/hep/fulltext/2024/06000/aasld_practice_guidance_on_acute_on_chronic_liver.25.aspx | AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis |
| EASL | 2023 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2823%2900244-1 | EASL Clinical Practice Guidelines on acute-on-chronic liver failure |
| EASL | 2017 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2816%2930708-5 | EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure |
| AASLD | 2013 | https://journals.lww.com/hep/Fulltext/2014/03000/Evaluation_for_liver_transplantation_in_adults_.42.aspx | Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation |
| AASLD | 2012 | https://onlinelibrary.wiley.com/doi/full/10.1002/lt.23566 | Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| EASL | 2025 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2824%2902508-X | EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma |
| AASLD | 2025 | https://journals.lww.com/hep/fulltext/2025/07000/critical_update__aasld_practice_guidance_on.26.aspx | Critical Update: AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma |
| EASL-ILCA | 2023 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2823%2900185-X | EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma |
| AASLD | 2023 | https://journals.lww.com/hep/fulltext/2023/02000/aasld_practice_guidance_on_primary_sclerosing.29.aspx | AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma |
| AASLD | 2023 | https://journals.lww.com/hep/fulltext/2023/12000/aasld_practice_guidance_on_prevention,_diagnosis,.27.aspx | AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| ACG | 2024 | https://journals.lww.com/ajg/fulltext/2024/07000/acg_clinical_guideline__focal_liver_lesions.13.aspx | ACG Clinical Guideline: Focal Liver Lesions |
| EASL | 2022 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900347-6 | EASL Clinical Practice Guidelines on the management of cystic liver diseases |
| EASL | 2017 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2816%2930101-5 | EASL Clinical Practice Guidelines on the management of benign liver tumours |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| EASL–EASD–EASO | 2024 | https://link.springer.com/article/10.1007/s00125-024-06196-3?utm_source=chatgpt.com | EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD): Executive Summary |
| AASLD | 2024 | https://journals.lww.com/hep/fulltext/2024/05000/metabolic_dysfunction_associated_steatotic_liver.23.aspx | Metabolic dysfunction–associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease |
| AASLD | 2024 | https://journals.lww.com/hep/fulltext/2025/01000/resmetirom_therapy_for_metabolic.28.aspx | Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance |
| AGA | 2023 | https://www.gastrojournal.org/article/S0016-5085(23)00881-8/fulltext | AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review |
| AASLD | 2023 | https://journals.lww.com/hep/Fulltext/2023/05000/AASLD_Practice_Guidance_on_the_clinical_assessment.31.aspx | AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease |
| EASL–EASD–EASO | 2016 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2815%2900734-5 | EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| AASLD | 2019 | https://journals.lww.com/hep/fulltext/2020/01000/diagnosis_and_treatment_of_alcohol_associated.25.aspx | Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases |
| EASL | 2018 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2818%2930214-9 | EASL Clinical Practice Guidelines: Management of alcohol-related liver disease |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| EASL | 2024 | https://www.jhep-reports.eu/action/showPdf?pii=S2589-5559%2823%2900264-1 | Expert management of congenital portosystemic shunts and their complications |
| AASLD | 2020 | https://journals.lww.com/hep/fulltext/2021/01000/vascular_liver_disorders,_portal_vein_thrombosis,.26.aspx | Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases |
| EASL | 2016 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2815%2900547-4 | EASL Clinical Practice Guidelines: Vascular diseases of the liver |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| EASL | 2019 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2818%2932177-9 | EASL Clinical Practice Guidelines on nutrition in chronic liver disease |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| AASLD | 2025 | https://journals.lww.com/hep/fulltext/2025/01000/aasld_practice_guideline_on_blood_based.29.aspx | AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis |
| AASLD | 2025 | https://journals.lww.com/hep/fulltext/2025/02000/aasld_practice_guideline_on_imaging_based.30.aspx | AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis |
| AASLD | 2025 | https://journals.lww.com/hep/fulltext/2025/03000/aasld_practice_guideline_on_noninvasive_liver.30.aspx | AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension |
| EASL | 2021 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2821%2900398-6 | EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis– 2021 update |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| EASL | 2024 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2824%2900274-5 | EASL Clinical Practice Guidelines on genetic cholestatic liver diseases |
| EASL | 2022 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2821%2902227-3 | Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder |
| EASL | 2019 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2819%2930474-X | EASL Clinical Practice Guideline: Occupational liver diseases |
| EASL | 2022 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900211-2 | EASL Clinical Practice Guidelines on haemochromatosis |
| AASLD | 2011 | https://journals.lww.com/hep/Fulltext/2011/07000/Diagnosis_and_management_of_hemochromatosis__2011.36.aspx | Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases |
| EASL-ERN | 2025 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2824%2902706-5 | EASL-ERN Clinical Practice Guidelines on Wilson’s disease |
| AASLD | 2022 | https://journals.lww.com/hep/fulltext/9900/a_multidisciplinary_approach_to_the_diagnosis_and.207.aspx | A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases |
| AASLD | 2023 | https://journals.lww.com/hep/fulltext/2023/03000/aasld_practice_guidance_on_drug,_herbal,_and.28.aspx | AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| AGA | 2024 | https://www.gastrojournal.org/article/S0016-5085(24)05118-7/fulltext | AGA Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review |
| EASL | 2023 | https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2823%2900181-2 | EASLClinical Practice Guidelines on the management of liver diseases in pregnancy |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| AASLD | 2024 | https://journals.lww.com/hep/fulltext/2024/01000/aasld_practice_guidance_on_the_use_of_tips,.23.aspx | AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| AASLD | 2021 | https://journals.lww.com/hep/fulltext/2021/01000/reproductive_health_and_liver_disease__practice.25.aspx | Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases |
| ΟΡΓΑΝΩΣΗ | ΕΤΟΣ | LINK / PDF | Guidelines title |
| BAVENO VII | 2025 | https://www.journal-of-hepatology.eu/article/S0168-8278(21)02299-6/fulltext | Baveno VII- Renewing consensus in portal hypertension |